網膜イメージングデバイスの市場規模、シェア、動向分析レポート：デバイス別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

網膜イメージング装置市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の網膜イメージングデバイス市場規模は、2024～2030年にかけてCAGR 7.9％を記録し、2030年には63億5,000万米ドルに達すると予測されています。

同市場はいくつかの主要要因によって牽引されています。主要市場促進要因の1つは、糖尿病網膜症、加齢黄斑変性（AMD）、緑内障などの網膜疾患の有病率の増加です。これらの疾患は、人口の高齢化と糖尿病や高血圧などの生活習慣病の増加により一般的になりつつあり、目の健康に直接的な影響を及ぼしています。その結果、これらの疾患を早期かつ正確に検出し、患者の予後改善と目の健康のより効果的な管理につながる高度な診断ツールに対する需要が高まっています。

市場の拡大には、技術の進歩が重要な役割を果たしています。光干渉断層計（OCT）、眼底写真、自動画像解析のための人工知能（AI）の統合などの技術革新は、網膜画像の精度と効率を大幅に向上させています。例えば、Nikonが2022年3月に発表したUWF網膜イメージング技術は、日本市場を劇的に押し上げます。このUWF画像は、1枚の画像で網膜の最大200度を捉え、糖尿病網膜症やAMDなどの網膜疾患の検出と管理を強化します。これは、日本の高齢化によって高まる高度な診断ツールへの需要に応えるものです。これらの技術により、網膜疾患のより早期かつ正確な診断が可能になり、視力低下の予防に不可欠です。特にAI主導のソリューションは、複雑な網膜画像を分析するための洗練されたツールを眼科医に提供することで、より多くの情報に基づいた意思決定と個別化された治療計画を促進し、このセグメントに変革をもたらしつつあります。

市場の競合情勢は、複数の大手企業の存在によって特徴付けられています。これらの企業は、最新技術の進歩を取り入れた継続的な製品のアップグレード、戦略的提携、買収機会の模索などの戦略を通じて、製品ポートフォリオを積極的に強化しています。製品の信頼性を高め、市場参入を容易にする規制基準への準拠を確実にするためには、製品の政府承認取得も極めて重要です。

政府の取り組みやプログラムは、市場の成長に大きく貢献しています。多くの政府は、眼疾患の早期発見と管理を促進するため、公衆衛生キャンペーンやスクリーニング・プログラムに投資しています。このような取り組みは、定期的な眼科検診の重要性に対する認識を高めるだけでなく、高度な網膜画像処理技術に対する需要を促進しています。さらに、技術革新や医療インフラへの投資を支援する有利な規制の枠組みや政策が、市場成長を促す環境を作り出しています。このような取り組みは、最先端の網膜画像診断装置をより多くの人々が利用できるようにし、最終的に世界規模で眼の健康状態を改善するために不可欠です。

市場の主要参入企業としては、Carl Zeiss Meditec AG、Topcon Corporation、NIDEK Co., Ltd.、Heidelberg Engineering GmbH、Optos Plc (a Nikon Company)、Canon Inc.、Alcon Inc.、Bausch + Lomb (Bausch Health Companies Inc.の一部門)、Optovue, Inc.,、Essilor International、Olympus Visionなどが挙げられます。2024年4月には、AEYEのAIを搭載したハンドヘルド眼底カメラOptomed AuroraがFDAの認可を取得したと発表しました。これらの参入企業は、世界の顧客に対応するため、製品の発売や承認など様々な戦略的取り組みを行っています。

網膜イメージングデバイス市場レポートハイライト

• デバイス別では、光コヒーレンストモグラフィ（OCT）デバイスが2023年に28.9%の最大売上シェアを占めました。光コヒーレンストモグラフィ（OCT）は、生体組織の高解像度断面画像を得るために使用される非侵襲的イメージング技術です。OCTは、網膜の層の詳細な視覚化を可能にし、黄斑変性症、糖尿病性網膜症（DR）、緑内障などの様々な眼疾患の診断と管理を支援する、眼科における重要なツールとなっています。
• DRやAMDなどの網膜疾患の有病率の増加は、市場の疾患診断セグメントの重要な促進要因です。
• 適応症別では、糖尿病網膜症セグメントが適応症セグメントを支配し、2023年に32.1％の最大市場シェアを占める。糖尿病性網膜症の世界の有病率の増加に伴い、高度な診断とモニタリング技術へのニーズが急増し、同セグメントの高い市場シェアに寄与しています。
• 最終用途別では、病院セグメントが2023年に39.5％の最大市場シェアを占めています。これは、網膜障害の早期発見を可能にし、迅速な介入と治療を可能にする病院における高度なイメージング技術に起因します。さらに、臨床ニーズを満たすための病院と他の企業との提携・協力関係も市場成長に寄与しています。
• 北米は、確立された医療部門、イノベーションへのコミットメント、先進的なインフラ、研究開発の重視、網膜疾患の高い有病率、革新的技術の急速な導入などの要因により、世界市場を独占しています。
• アジア太平洋は、2024～2030年までの予測期間においてCAGR 8.6％で急成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 網膜イメージングデバイス市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 網膜イメージングデバイス市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 網膜イメージングデバイス市場：デバイス別、推定・動向分析

• セグメントダッシュボード
• 世界の網膜イメージングデバイス、デバイス市場変動分析
• 世界の網膜イメージングデバイス市場規模と動向分析、デバイス別、2018～2030年
• 光干渉断層撮影（OCT）装置
• フルオレセイン蛍光眼底造影装置
• 眼底カメラ
• 網膜超音波画像診断システム
• 超広視野網膜イメージング装置
• 広視野網膜イメージング装置

第5章 網膜イメージングデバイス市場：用途別、推定・動向分析

• セグメントダッシュボード
• 世界の網膜イメージングデバイス、用途市場変動分析
• 世界の網膜イメージングデバイス市場規模と動向分析、用途別、2018～2030年
• 疾病診断
  • 疾病診断市場推定・予測、2018～2030年
• 治療モニタリング
  • 治療モニタリング市場推定・予測、2018～2030年
• 研究開発
  • 研究開発市場推定・予測、2018～2030年

第6章 網膜イメージングデバイス市場：適応症別、推定・動向分析

• セグメントダッシュボード
• 世界の網膜イメージングデバイス、適応症市場変動分析
• 世界の網膜イメージングデバイス市場規模と動向分析、適応症別、2018～2030年
• 糖尿病網膜症
• 加齢黄斑変性症（AMD）
• 緑内障
• 網膜静脈閉塞症
• その他

第7章 網膜イメージングデバイス市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界の網膜イメージングデバイス、最終用途市場変動分析
• 世界の網膜イメージングデバイス市場規模と動向分析、最終用途別、2018～2030年
• 病院
• 眼科クリニック
• 外来手術センター
• その他

第8章 網膜イメージングデバイス市場：デバイス、用途、適応症、最終用途別の地域別、推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 世界地域市場スナップショット
• 市場規模と予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2023年
• Company Position Analysis
• 企業分類（新興企業、イノベーター、リーダー）
• 企業プロファイル
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • NIDEK CO., LTD.
  • Optos
  • Canon Medical Systems
  • Essilor Instruments
  • Optomed
  • Lumibird Medical
  • Heidelberg Engineering Inc.
  • Visionix
  • OPTOPOL Technology Sp

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 North America retinal imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 4 North America retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 5 North America retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 6 North America retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 7 North America retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 8 US retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 9 U.S. retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 10 U.S. retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 11 U.S. retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 12 Canada retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 13 Canada retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 14 Canada retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 15 Canada retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 16 Mexico retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 17 Mexico retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 18 Mexico retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 19 Mexico retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 20 Europe retinal imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 21 Europe retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 22 Europe retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 23 Europe retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 24 Europe retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 25 UK retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 26 UK retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 27 UK retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 28 UK retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 29 Germany retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 30 Germany retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 31 Germany retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 32 Germany retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 33 France retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 34 France retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 35 France retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 36 France retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 37 Italy retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 38 Italy retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 39 Italy retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 40 Italy retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 41 Denmark retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 42 Denmark retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 43 Denmark retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 44 Denmark retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 45 Sweden retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 46 Sweden retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 47 Sweden retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 48 Sweden retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 49 Norway retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 50 Norway retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 51 Norway retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 52 Norway retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific retinal imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 57 Asia Pacific retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 58 Japan retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 59 Japan retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 60 Japan retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 61 Japan retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 62 China retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 63 China retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 64 China retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 65 China retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 66 India retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 67 India retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 68 India retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 69 India retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 70 Australia retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 71 Australia retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 72 Australia retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 73 Australia retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 74 South Korea retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 75 South Korea retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 76 South Korea retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 77 South Korea retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 78 Thailand retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 79 Thailand retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 80 Thailand retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 81 Thailand retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 82 Latin America retinal imaging devices market, By Country, 2018 - 2030 (USD Million)
• Table 83 Latin America retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 84 Latin America retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 85 Latin America retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 86 Latin America retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 87 Brazil retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 88 Brazil retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 89 Brazil retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 90 Brazil retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 91 Argentina retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 92 Argentina retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 93 Argentina retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 94 Argentina retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 95 Middle East & Africa retinal imaging devices market, By country, 2018 - 2030 (USD Million)
• Table 96 Middle East & Africa retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 97 Middle East & Africa retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 98 Middle East & Africa retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 99 Middle East & Africa retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 100 South Africa retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 101 South Africa retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 102 South Africa retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 103 South Africa retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 104 Saudi Arabia retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 105 Saudi Arabia retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 108 UAE retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 109 UAE retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 110 UAE retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 111 UAE retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)
• Table 112 Kuwait retinal imaging devices market, By device, 2018 - 2030 (USD Million)
• Table 113 Kuwait retinal imaging devices market, By application, 2018 - 2030 (USD Million)
• Table 114 Kuwait retinal imaging devices market, By indications, 2018 - 2030 (USD Million)
• Table 115 Kuwait retinal imaging devices market, By end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Retinal imaging devices market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation technique
• Fig. 4 Commodity workflow analysis
• Fig. 5 Parent market analysis
• Fig. 6 Market snapshot
• Fig. 7 Segment snapshot (Device Type)
• Fig. 8 Segment snapshot (Application)
• Fig. 9 Segment snapshot (Indication)
• Fig. 10 Segment snapshot (End Use)
• Fig. 11 Competitive landscape
• Fig. 12 Ophthalmic devices and retinal imaging devices market value, 2023 (USD Billion)
• Fig. 13 Retinal imaging devices market dynamics
• Fig. 14 Percentage of 2021 U.S. diabetic population with DR by stage and age group
• Fig. 15 Percentage distribution of the population aged 65 years & over by region: 2015 and 2050
• Fig. 16 Projection of older population in the U.S. (in Millions), 2016-2050
• Fig. 17 Retinal imaging devices market: PORTER's analysis
• Fig. 18 Retinal imaging devices market: PESTEL analysis
• Fig. 19 Retinal imaging devices market: By device type: Key takeaways
• Fig. 20 Retinal imaging devices market, by device type: Market share, 2023 & 2030
• Fig. 21 Optical Coherence Tomography (OCT) devices market, 2018 - 2030 (USD Million)
• Fig. 22 Spectral-domain OCT (SD-OCT) market, 2018 - 2030 (USD Million)
• Fig. 23 Swept source OCT (SS-OCT) market, 2018 - 2030 (USD Million)
• Fig. 24 Handheld OCT market, 2018 - 2030 (USD Million)
• Fig. 25 Fundus cameras market, 2018 - 2030 (USD Million)
• Fig. 26 Mydriatic fundus cameras market, 2018 - 2030 (USD Million)
• Fig. 27 Non-mydriatic fundus cameras market, 2018 - 2030 (USD Million)
• Fig. 28 Hybrid fundus cameras market, 2018 - 2030 (USD Million)
• Fig. 29 ROP fundus cameras market, 2018 - 2030 (USD Million)
• Fig. 30 Fluorescein angiography devices market, 2018 - 2030 (USD Million)
• Fig. 31 Retinal ultrasound imaging systems market, 2018 - 2030 (USD Million)
• Fig. 32 Ophthalmic A-scan ultrasound market, 2018 - 2030 (USD Million)
• Fig. 33 Ophthalmic B-scan ultrasound market, 2018 - 2030 (USD Million)
• Fig. 34 Ophthalmic ultrasound biomicroscopes market, 2018 - 2030 (USD Million)
• Fig. 35 Ophthalmic pachymeters market, 2018 - 2030 (USD Million)
• Fig. 36 Widefield retinal imaging devices market, 2018 - 2030 (USD Million)
• Fig. 37 Ultra widefield retinal imaging devices market, 2018 - 2030 (USD Million)
• Fig. 38 Other devices market, 2018 - 2030 (USD Million)
• Fig. 39 Retinal imaging devices market: By application: Key takeaways
• Fig. 40 Retinal imaging devices market, by application: Market share, 2023 & 2030
• Fig. 41 Disease diagnosis market, 2018 - 2030 (USD Million)
• Fig. 42 Treatment monitoring market, 2018 - 2030 (USD Million)
• Fig. 43 Research and development market, 2018 - 2030 (USD Million)
• Fig. 44 Retinal imaging devices market: By indication: Key takeaways
• Fig. 45 Retinal imaging devices market, by indication: Market share, 2023 & 2030
• Fig. 46 Percentage of U.S. resident population with Diabetic Retinopathy (DR), by stage, gender, and race/ethnicity, 2021
• Fig. 47 Diabetic retinopathy market, 2018 - 2030 (USD Million)
• Fig. 48 Age-related Macular Degeneration (AMD) market, 2018 - 2030 (USD Million)
• Fig. 49 Glaucoma market, 2018 - 2030 (USD Million)
• Fig. 50 Retinal vein occlusion market, 2018 - 2030 (USD Million)
• Fig. 51 Other indications market, 2018 - 2030 (USD Million)
• Fig. 52 Retinal imaging devices market: By end use: Key takeaways
• Fig. 53 Retinal imaging devices market, by end use: Market share, 2023 & 2030
• Fig. 54 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 55 Ophthalmology clinics market, 2018 - 2030 (USD Million)
• Fig. 56 Ambulatory surgical centers (ASCs) market, 2018 - 2030 (USD Million)
• Fig. 57 Others market, 2018 - 2030 (USD Million
• Fig. 58 Global retinal imaging devices market: Regional movement analysis
• Fig. 59 Global retinal imaging devices market: Regional outlook and key takeaways
• Fig. 60 North America
• Fig. 61 North America market estimates and forecasts, 2018 - 2030
• Fig. 62 U.S.
• Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 64 Canada
• Fig. 65 Canada market estimates and forecasts, 2018 - 2030
• Fig. 66 Mexico
• Fig. 67 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 68 Europe
• Fig. 69 Europe market estimates and forecasts, 2018 - 2030
• Fig. 70 UK
• Fig. 71 UK market estimates and forecasts, 2018 - 2030
• Fig. 72 Germany
• Fig. 73 Germany market estimates and forecasts, 2018 - 2030
• Fig. 74 France
• Fig. 75 France market estimates and forecasts, 2018 - 2030
• Fig. 76 Italy
• Fig. 77 Italy market estimates and forecasts, 2018 - 2030
• Fig. 78 Spain
• Fig. 79 Spain market estimates and forecasts, 2018 - 2030
• Fig. 80 Denmark
• Fig. 81 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 82 Sweden
• Fig. 83 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 84 Norway
• Fig. 85 Norway market estimates and forecasts, 2018 - 2030
• Fig. 86 Asia Pacific
• Fig. 87 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 88 China
• Fig. 89 China market estimates and forecasts, 2018 - 2030
• Fig. 90 Japan
• Fig. 91 Japan market estimates and forecasts, 2018 - 2030
• Fig. 92 India
• Fig. 93 India market estimates and forecasts, 2018 - 2030
• Fig. 94 Thailand
• Fig. 95 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 96 South Korea
• Fig. 97 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 98 Australia
• Fig. 99 Australia market estimates and forecasts, 2018 - 2030
• Fig. 100 Latin America
• Fig. 101 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 102 Brazil
• Fig. 103 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 104 Mexico
• Fig. 105 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 106 Argentina
• Fig. 107 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 108 Middle East and Africa
• Fig. 109 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 110 South Africa
• Fig. 111 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 112 Saudi Arabia
• Fig. 113 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 114 UAE
• Fig. 115 UAE market estimates and forecasts, 2018 - 2030
• Fig. 116 Kuwait
• Fig. 117 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 118 Market share of key market players- Retinal Imaging Devices market

Retinal Imaging Devices Market Growth & Trends:

The global retinal imaging devices market size is expected to reach USD 6.35 billion by 2030, registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors. One of the primary market drivers is the increasing prevalence of retinal disorders, such as diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma. These conditions are becoming more common due to an aging population and a rise in lifestyle-related diseases like diabetes and hypertension, which have direct implications for eye health. As a result, there is a growing demand for advanced diagnostic tools that can detect these disorders early and accurately, leading to better patient outcomes and more effective management of eye health.

Technological advancements are playing a crucial role in the expansion of the market. Innovations such as optical coherence tomography (OCT), fundus photography, and the integration of artificial intelligence (AI) for automated image analysis are significantly enhancing the accuracy and efficiency of retinal imaging. For instance, Nikon's UWF retinal imaging technology launch in March 2022 dramatically boosts Japan's market. This UWF imaging captures up to 200 degrees of the retina in one image, enhancing the detection and management of retinal diseases such as diabetic retinopathy and AMD. It meets the growing demand for advanced diagnostic tools driven by Japan's aging population. These technologies enable earlier and more precise diagnosis of retinal disorders, which is essential for preventing vision loss. AI-driven solutions, in particular, are transforming the field by providing ophthalmologists with sophisticated tools for analyzing complex retinal images, thereby facilitating more informed decision-making and personalized treatment plans.

The competitive landscape in the market is characterized by the presence of several major players. These companies are actively enhancing their product portfolios through strategies such as continuous product upgrades to incorporate the latest technological advancements, strategic collaborations, and exploring opportunities for acquisitions. Obtaining government approvals for their products is also crucial to ensure compliance with regulatory standards, which can enhance product credibility and facilitate market entry.

Government initiatives and programs are significantly contributing to the growth of the market. Many governments are investing in public health campaigns and screening programs to promote the early detection and management of eye diseases. Such initiatives not only increase awareness about the importance of regular eye exams but also drive demand for advanced retinal imaging technologies. Additionally, favorable regulatory frameworks and policies that support innovation and investment in healthcare infrastructure are creating a conducive environment for market growth. These efforts are essential in ensuring that cutting-edge retinal imaging devices are accessible to a broader population, ultimately improving eye health outcomes on a global scale.

Some of the key players in the market are Carl Zeiss Meditec AG, Topcon Corporation, NIDEK Co., Ltd., Heidelberg Engineering GmbH, Optos Plc (a Nikon Company), Canon Inc., Alcon Inc., Bausch + Lomb (a division of Bausch Health Companies Inc.), Optovue, Inc., Essilor International, and Olympus Vision. In April 2024, the company announced that the Optomed Aurora handheld fundus camera, equipped with AEYE's AI, received FDA clearance. These players are involved in various strategic initiatives such as product launch and approval in order to cater to a global clientele.

Retinal Imaging Devices Market Report Highlights:

• Based on device, Optical Coherence Tomography (OCT) devices accounted for largest revenue share of 28.9% in 2023. Optical Coherence Tomography (OCT) is a noninvasive imaging technology used to obtain high-resolution cross-sectional images of biological tissues. OCT has become a critical tool in ophthalmology, enabling detailed visualization of the retina's layers and aiding in the diagnosis & management of various eye conditions, such as macular degeneration, Diabetic Retinopathy (DR), and glaucoma.
• Based on application, disease diagnosis dominated the market and accounted for the largest share of 53.9% in 2023.The increasing prevalence of retinal diseases, such as DR and AMD, is a significant driver for the disease diagnosis segment of the market.
• Based on indications, Diabetic retinopathy segment is dominated the indication segments with the largest market share of 32.1% in 2023. As increasing global prevalence of diabetic retinopathy increases, need for advanced diagnostic and monitoring technologies surges contributing to the segments high market share.
• Based on end use, hospitals segment is dominated the end use segments with the largest market share of 39.5% in 2023. This is attributable to advanced imaging technologies in hospitals that enable the early detection of retinal disorders, allowing for prompt intervention and treatment. In addition, partnerships & collaborations between hospitals and other companies to meet clinical needs contribute to market growth.
• North America dominated the global market due to the attributed to the well-established healthcare sector, commitment to innovation, advanced infrastructure, a strong emphasis on R&D, the high prevalence of retinal disorders, and rapid adoption of innovative technologies
• Asia Pacific region is expected to witness fastest growth with a CAGR of 8.6% over the forecast period from 2024 to 2030, due to presence of manufacturers with innovative devices manufacturing capabilities coupled with accelerated diagnostic research capabilities.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Device
  • 1.2.2. Application
  • 1.2.3. Indications
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Device outlook
  • 2.2.2. Application outlook
  • 2.2.3. Indications outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Retinal Imaging Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of retinal disorders
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Surge in the geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Shortage of skilled professionals
    • 3.2.2.2. Regulatory challenges
• 3.3. Retinal Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Retinal Imaging Devices Market: Device Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Retinal Imaging Devices Device Market Movement Analysis
• 4.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by Device, 2018 to 2030 (USD Million)
• 4.4. Optical Coherence Tomography (OCT) Devices
  • 4.4.1. Optical Coherence Tomography (OCT) Devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Spectral-Domain OCT (SD-OCT)
    • 4.4.2.1. Spectral-Domain OCT (SD-OCT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Swept-Source OCT (SS-OCT)
    • 4.4.3.1. Swept-Source OCT (SS-OCT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Handheld OCT
    • 4.4.4.1. Handheld OCT market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Fluorescein Angiography Devices
  • 4.5.1. Fluorescein angiography devices market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Fundus Cameras
  • 4.6.1. Fundus Cameras market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.2. Mydriatic Fundus Cameras
    • 4.6.2.1. Mydriatic fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.3. Non-Mydriatic Fundus Cameras
    • 4.6.3.1. Non-Mydriatic fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.4. Hybrid Fundus Cameras
    • 4.6.4.1. Hybrid fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6.5. ROP Fundus Cameras
    • 4.6.5.1. ROP fundus cameras market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Retinal Ultrasound Imaging Systems
  • 4.7.1. Retinal ultrasound imaging systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.2. Ophthalmic A-Scan Ultrasound
    • 4.7.2.1. Ophthalmic A-Scan ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.3. Ophthalmic B-Scan Ultrasound
    • 4.7.3.1. Ophthalmic B-Scan ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.4. Ophthalmic Ultrasound Biomicroscopes
    • 4.7.4.1. Ophthalmic ultrasound biomicroscopes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7.5. Ophthalmic Pachymeters
    • 4.7.5.1. Ophthalmic pachymeters market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Ultra widefield Retinal Imaging Devices
  • 4.8.1. Retinal ultrasound imaging systems market estimates and forecasts 2018 to 2030 (USD Million
• 4.9. Widefield Retinal Imaging Devices
  • 4.9.1. Widefield retinal imaging devices market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Retinal Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Retinal Imaging Devices Application Market Movement Analysis
• 5.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Disease Diagnosis
  • 5.4.1. Disease diagnosis market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Treatment Monitoring
  • 5.5.1. Treatment monitoring market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Research and Development
  • 5.6.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Retinal Imaging Devices Market: Indications Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Retinal Imaging Devices Indications Market Movement Analysis
• 6.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by Indications, 2018 to 2030 (USD Million)
• 6.4. Diabetic Retinopathy
  • 6.4.1. Diabetic retinopathy market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Age-Related Macular Degeneration (AMD)
  • 6.5.1. Age-Related Macular Degeneration (AMD) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Glaucoma
  • 6.6.1. Glaucoma market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Retinal Vein Occlusion
  • 6.7.1. Retinal vein occlusion market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Other Indications
  • 6.8.1. Other indications market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Retinal Imaging Devices Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Retinal Imaging Devices End Use Market Movement Analysis
• 7.3. Global Retinal Imaging Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Ophthalmology Clinics
  • 7.5.1. Ophthalmology clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Ambulatory surgery centers market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Retinal Imaging Devices Market: Regional Estimates & Trend Analysis By Device, Application, Indications, End Use

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 8.5. North America
  • 8.5.1. U.S.
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. Reimbursement structure
    • 8.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Canada
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement structure
    • 8.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement structure
    • 8.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. UK
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Reimbursement structure
    • 8.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement structure
    • 8.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. France
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement structure
    • 8.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Italy
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement structure
    • 8.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.5. Spain
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement structure
    • 8.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Norway
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement structure
    • 8.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.7. Sweden
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Competitive scenario
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement structure
    • 8.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.8. Denmark
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Competitive scenario
    • 8.6.8.3. Regulatory framework
    • 8.6.8.4. Reimbursement structure
    • 8.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Reimbursement structure
    • 8.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement structure
    • 8.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Competitive scenario
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement structure
    • 8.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Competitive scenario
    • 8.7.4.3. Regulatory framework
    • 8.7.4.4. Reimbursement structure
    • 8.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Competitive scenario
    • 8.7.5.3. Regulatory framework
    • 8.7.5.4. Reimbursement structure
    • 8.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Competitive scenario
    • 8.7.6.3. Regulatory framework
    • 8.7.6.4. Reimbursement structure
    • 8.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. Reimbursement structure
    • 8.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Regulatory framework
    • 8.8.2.4. Reimbursement structure
    • 8.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Competitive scenario
    • 8.9.1.3. Regulatory framework
    • 8.9.1.4. Reimbursement structure
    • 8.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Competitive scenario
    • 8.9.2.3. Regulatory framework
    • 8.9.2.4. Reimbursement structure
    • 8.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Competitive scenario
    • 8.9.3.3. Regulatory framework
    • 8.9.3.4. Reimbursement structure
    • 8.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Competitive scenario
    • 8.9.4.3. Regulatory framework
    • 8.9.4.4. Reimbursement structure
    • 8.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
• 9.3. Key company market share analysis, 2023
• 9.4. Company Position Analysis
• 9.5. Company Categorization (Emerging Players, Innovators and Leaders
• 9.6. Company Profiles
  • 9.6.1. Carl Zeiss Meditec AG
    • 9.6.1.1. Company overview
    • 9.6.1.2. Financial performance
    • 9.6.1.3. Product benchmarking
    • 9.6.1.4. Strategic initiatives
  • 9.6.2. Topcon Corporation
    • 9.6.2.1. Company overview
    • 9.6.2.2. Financial performance
    • 9.6.2.3. Product benchmarking
    • 9.6.2.4. Strategic initiatives
  • 9.6.3. NIDEK CO., LTD.
    • 9.6.3.1. Company overview
    • 9.6.3.2. Financial performance
    • 9.6.3.3. Product benchmarking
    • 9.6.3.4. Strategic initiatives
  • 9.6.4. Optos
    • 9.6.4.1. Company overview
    • 9.6.4.2. Financial performance
    • 9.6.4.3. Product benchmarking
    • 9.6.4.4. Strategic initiatives
  • 9.6.5. Canon Medical Systems
    • 9.6.5.1. Company overview
    • 9.6.5.2. Financial performance
    • 9.6.5.3. Product benchmarking
    • 9.6.5.4. Strategic initiatives
  • 9.6.6. Essilor Instruments
    • 9.6.6.1. Company overview
    • 9.6.6.2. Financial performance
    • 9.6.6.3. Product benchmarking
    • 9.6.6.4. Strategic initiatives
  • 9.6.7. Optomed
    • 9.6.7.1. Company overview
    • 9.6.7.2. Financial performance
    • 9.6.7.3. Product benchmarking
    • 9.6.7.4. Strategic initiatives
  • 9.6.8. Lumibird Medical
    • 9.6.8.1. Company overview
    • 9.6.8.2. Financial performance
    • 9.6.8.3. Product benchmarking
    • 9.6.8.4. Strategic initiatives
  • 9.6.9. Heidelberg Engineering Inc.
    • 9.6.9.1. Company overview
    • 9.6.9.2. Financial performance
    • 9.6.9.3. Product benchmarking
    • 9.6.9.4. Strategic initiatives
  • 9.6.10. Visionix
    • 9.6.10.1. Company overview
    • 9.6.10.2. Financial performance
    • 9.6.10.3. Product benchmarking
    • 9.6.10.4. Strategic initiatives
  • 9.6.11. OPTOPOL Technology Sp
    • 9.6.11.1. Company overview
    • 9.6.11.2. Financial performance
    • 9.6.11.3. Product benchmarking
    • 9.6.11.4. Strategic initiatives